Results 251 to 260 of about 148,446 (303)
Some of the next articles are maybe not open access.
The Lancet, 2021
Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that affects nearly 10 million people every year worldwide. Strong provoking risk factors for venous thromboembolism include major surgery and active cancer, but most events are unprovoked.
Khan, Faizan +3 more
openaire +4 more sources
Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that affects nearly 10 million people every year worldwide. Strong provoking risk factors for venous thromboembolism include major surgery and active cancer, but most events are unprovoked.
Khan, Faizan +3 more
openaire +4 more sources
American Journal of Respiratory and Critical Care Medicine, 1999
Incidence of venous thromboembolism (VTE) in children is rapidly rising. Frequent use of central venous lines (CVLs) in children with a variety of disease processes has contributed to increased incidence of VTE. In addition, increased detection of VTE has been possible due to the availability of sensitive imaging studies such as Color Duplex/Doppler ...
R, Gera, R, Kulkarni
openaire +4 more sources
Incidence of venous thromboembolism (VTE) in children is rapidly rising. Frequent use of central venous lines (CVLs) in children with a variety of disease processes has contributed to increased incidence of VTE. In addition, increased detection of VTE has been possible due to the availability of sensitive imaging studies such as Color Duplex/Doppler ...
R, Gera, R, Kulkarni
openaire +4 more sources
Current Opinion in Cardiology, 1991
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
R D, Hull, G E, Raskob
openaire +2 more sources
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
R D, Hull, G E, Raskob
openaire +2 more sources
Venous Thromboembolism Overview
Hematology/Oncology Clinics of North America, 2012This article gives a general overview of venous thromboembolism (VTE). Pathophysiology, presentation, diagnosis, and initial management of VTE are briefly reviewed. More difficult management problems are reviewed in greater depth, including duration of anticoagulation, treatment of superficial venous thrombosis, and controversies surrounding bridging ...
Elisabeth M, Battinelli +2 more
openaire +2 more sources
Vascular Medicine, 2012
A 61-year-old man was admitted to an outside medical facility with left leg deep vein thrombosis and bilateral pulmonary emboli. His clinical course was complicated by hypotension, azotemia and declining mental status. Positive blood cultures for gram-positive cocci prompted transfer to our institution.
Dmitriy, Golovyan +2 more
openaire +2 more sources
A 61-year-old man was admitted to an outside medical facility with left leg deep vein thrombosis and bilateral pulmonary emboli. His clinical course was complicated by hypotension, azotemia and declining mental status. Positive blood cultures for gram-positive cocci prompted transfer to our institution.
Dmitriy, Golovyan +2 more
openaire +2 more sources
Journal of the American Medical Association, 1946
The active rational medical prophylaxis of pulmonary embolism by the use of heparin has been discouraged because of the involved technical procedures required for maintaining continuous anticoagulant effects. Although recent reports on the routine use of dicumarol have been promising,1the potential hazards, the unpredictable treatment failures and the ...
L, LOEWE, P, ROSENBLATT, E, HIRSCH
openaire +2 more sources
The active rational medical prophylaxis of pulmonary embolism by the use of heparin has been discouraged because of the involved technical procedures required for maintaining continuous anticoagulant effects. Although recent reports on the routine use of dicumarol have been promising,1the potential hazards, the unpredictable treatment failures and the ...
L, LOEWE, P, ROSENBLATT, E, HIRSCH
openaire +2 more sources